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The Challenge of Implementing
Cervical Cancer Prevention in
the Developing World
Invasive cervical cancer (ICC) is a
leading cause of cancer-related mortality
and morbidity among women in the
developing world [1]. Numerous demon-
stration projects have proven the efficacy
of simplified ‘‘screen and treat’’ approach-
es (such as visual inspection with acetic
acid [VIA] and immediate cryotherapy)
for cervical cancer prevention in low
income countries [2–5]. Yet, rarely have
they been adopted and scaled up by
governments in such settings, and as a
result rates of screening coverage in the
developing world remain low [6]. In
Zambia, which has the world’s second
highest annual cervical cancer incidence
and mortality rates [1], we initiated a
unique partnership for providing cervical
cancer prevention services within the
public sector health care system. The
Cervical Cancer Prevention Program in
Zambia (CCPPZ), launched in 2006 and
initially targeting the highest risk HIV-
infected women, has cumulatively provid-
ed services to over 58,000 women (re-
gardless of HIV status) over the past 5
years [7,8] (Figure 1). Our previous
reports have described the disease burden
[9,10,11], program implementation expe-
rience [7], telecommunications matrix
utilized for distance consultation and
quality assurance [8], outcomes of a
referral system for women ineligible for
treatment with cryotherapy [12], com-
mon myths and misconceptions surround-
ing cervical cancer [13], and an analysis
of outcomes and effectiveness of screening
among women with HIV [11]. In this
article, we discuss the unique attributes of
the program’s successful implementation,
including its adoptability to the conditions
of a resource-constrained environment,
integration with infrastructure of an
HIV/AIDS program, use of innovative
quality assurance measures, and the
potential for sustainability and collateral
impact (Figure 2). The global ‘‘call to
action’’ for cancer control in low in-
come countries is emerging [14], yet
funding for stand-alone cancer prevention
initiatives is virtually non-existent. Our
experience may provide insights and
guidance for advancing cancer preven-
tion initiatives in resource-constrained
settings.
The Cervical Cancer Prevention
Program in Zambia (CCPPZ)
CCPPZ is a unique partnership be-
tween Zambian and United States part-
ner institutions from the academic (Uni-
versity Teaching Hospital [UTH] in
Lusaka and University of Alabama at
Birmingham [UAB]), research (Centre
for Infectious Disease Research in Zam-
bia [CIDRZ]), and governmental (Zam-
bian Ministry of Health) sectors. Preven-
tion efforts have been rapidly scaled up,
taking advantage of a historical circum-
stance of increased attention and funding
in the HIV/AIDS sector through the US
President’s Emergency Plan for AIDS
Relief (PEPFAR) program [15]. Trained
nurses form the backbone of the pro-
gram, providing free personalized clinical
screening examinations for all eligible
women who attend the clinic [7,11]. VIA
aided by a low-cost digital camera
adaptation (‘‘digital cervicography’’) is
used to provide results immediately
[11]. Decisions about offering immediate
cryotherapy (‘‘screen-and-treat’’) or refer-
ral are made independently by nurses in
most cases, or aided by telemedicine
consultations with local doctors [11].
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follow-up after 1 year, VIA-positive and
cryotherapy-eligible women are treated
by the nurses, and those needing referral
are advised to attend the Gynecologic
Cancer Prevention Unit in the UTH
[12]. Administrative support is provided
by CIDRZ, while program operations
are integrated with the Zambian Ministry
of Health’s public sector health care
infrastructure [7]. From 2006 to March
2011, over 58,000 women, regardless of
HIV status, have been screened in this
program. Of the initial 21,010 women
who were provided services in the
program (31% of whom had HIV),
38% were VIA positive, of whom 62%
were eligible for cryotherapy and 38%
were referred for histologic evaluation.
Forty-nine percent of patients referred
for histologic evaluation complied, and
pathology results revealed benign abnor-
malities in 8%, CIN1 in 28%, CIN2/3 in
26%, and ICC in 19% (of which 55%
were early stage).
Low-Tech Yet Scalable
Prevention Intervention
Modality
The dearth of adequately trained
cytotechnologists and pathologists, and
the requirement for multiple patient visits,
preclude successful utilization of cervical
cytology (‘‘Pap smears’’) in most of the
developing world [5]. Testing for cervical
human papillomavirus (HPV) is a highly
accurate screening approach, [16,17]
Summary Points
N Invasive cervical cancer is a leading cause of cancer-related death and morbidity
among women in the developing world.
N Screening coverage rates are very low in developing countries despite there
being proven, simple, ‘‘screen and treat’’ approaches for cervical cancer
prevention.
N In 2006 we initiated a partnership with the public health system in Zambia and
created the Cervical Cancer Prevention Program in Zambia (CCPPZ), targeting
the highest risk HIV-infected women, and have provided services to over 58,000
women (regardless of HIV status) over the past 5 years.
N We have demonstrated a strategy for using the availability, momentum, and
capacity-building efforts of vertical HIV/AIDS care and treatment programs to
implement a setting-appropriate protocol for cervical cancer prevention within
public health infrastructures.
N We report our lessons learned to help other cervical cancer prevention
initiatives succeed in the developing world and to avoid additional burdens on
health systems.
Figure 1. Cumulative enrollment graph of women accessing services in the Cervical Cancer Prevention Program in Zambia between
2006 and 2010.
doi:10.1371/journal.pmed.1001032.g001
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cially available HPV testing technology
makes routine implementation in low
income countries impractical, if not
impossible [18]. VIA linked to cryother-
apy has unique strengths (it can be done
by mid-level health care providers, and
has immediate results that allow linking
screening and treatment in the same visit),
but also antecedent weaknesses (higher
potential for false-positive results, and
limitations in ensuring quality assurance
[5]). Nonetheless, VIA remains the only
available option for a setting like Zambia.
We enhanced its application through the
use of digital photography (cervicography)
as a routine adjunct to ensure quality as
well as help with patient education and
electronic record keeping, and rapid
distance consultation with the limited
number of available physician experts,
when necessary [8]. Our model facilitated
program scale-up, despite limited resourc-
es. In fact, our experience suggests that
while the accuracy of a screening test is an
important attribute, it is only a small part
of the equation for mitigating cervical
cancer. Ultimately, the success of cervical
cancer prevention interventions is largely
determined by how screening and treat-
ment activities are integrated within the
routine health care system to ensure
maximal impact, an enduring goal of
our program.
Horizontal Integration with
Donor-Funded HIV/AIDS Care
and Treatment Programs
The increasing expansion, over the
past decade, of bilateral (e.g., PEPFAR)
and multilateral (e.g., Global Fund)
donor funding for HIV/AIDS programs
has transformed health care delivery in
resource limited settings, particularly in
sub-Saharan Africa [19]. With support
from PEPFAR and private donations,
CCPPZ’s cervical cancer prevention clin-
ics are co-located within public health
clinics offering HIV/AIDS care and
treatment. Manifold advantages of this
strategy include resource and infrastruc-
ture sharing, availability of a wider range
of women’s health services for HIV-
infected/at-risk women, and opportuni-
ties for referral between the clinic systems
and maximization of participation in
both programs. Yet, the stigma associat-
ed with HIV/AIDS continues to be a
challenge in Zambia, which drove our
decision to keep service provisions and
the identities of the cervical cancer and
HIV/AIDS care programs distinct, albeit
in the same premises. Women attending
cervical cancer screening clinics with
unknown HIV status are offered HIV
testing within the confidential environ-
ment of the screening rooms. Indeed,
cervical cancer itself is stigmatized, and
anxiety and fear often keep women from
getting screened [13]. In response, the
program is branded as a ‘‘Cervical
Health’’ program, which deemphasizes
cancer while denoting a positive
(‘‘health’’) connotation to the effort.
Innovations Using Information
Technology
One of the most enabling and trans-
forming aspects of the program involves
utilizing information technology tools
for enhancing the program’s operations
and enabling quality assurance. Tele-
medicine consultation through the ‘‘elec-
tronic cervical cancer control’’ model
[8] is a mobile health application that
has enhanced clinical care services
and improved quality assurance of
nurse-led VIA. The use of community
volunteers as patient-tracking officers,
taking advantage of the wide usage of
cell phone–based communication among
the patient population, is now promoting
adherence to the already minimized
follow-up visit requirements. The use of
point-of-care online data entry (under-
taken by nurses and their community
volunteer assistants), and a centralized
Web-based patient clinical and labora-
tory records management system are
enhancing program monitoring and out-
comes evaluation.
Figure 2. Program evaluation indicators of the Cervical Cancer Prevention Program in Zambia.
doi:10.1371/journal.pmed.1001032.g002
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Promise of Sustainability
The program is, by design, integrated
with the operations of the public health
system run and operated by the Zambian
Ministry of Health, a model that has
helped its transition from being a foreign-
funded/led project to a locally/nationally
‘‘owned’’ program. Program nurses are
recruited from the public sector health
care system, with add-on financial incen-
tives to facilitate retention. The program
also employs community-based volunteers
to serve as ‘‘peer educators’’ to facilitate
community awareness, counteract mis-
conceptions and myths, and serve patient
support functions [13]. All referral servic-
es are located within UTH, the only state-
run tertiary hospital in Zambia, which
permits medical and surgical services
(including loop electrosurgical excision
procedures [LEEP], hysterectomy, radia-
tion, and chemotherapy) at low-to-no cost
to patients. The need for coordination of
various administrative, clinical, and labo-
ratory (referral-level) services are achieved
through locally employed Zambian na-
tionals, with technical assistance from
expatriate American clinicians and ad-
ministrators living within the country, in a
‘‘shared leadership’’ model (Figure 3).
The motto of the program (‘‘Every
woman has the right to live a life free
from cervical cancer’’) encapsulates the
rights-based approach to women’s health,
designed to promote community-based
acceptance of this program. The pro-
gram’s infrastructure has facilitated the
development of a linked clinical, epide-
miological, and translational research
platform supported by numerous extra-
mural research and training grants and
contracts. Opportunities abound for en-
gaging Zambian and foreign clinical and
research trainees. The program’s success-
ful expansion in the Lusaka area has
leveraged political will for nationwide
expansion, as well as eventual roll out of
HPV vaccination and HPV-based screen-
ing [20] as the logical next steps in its
evolution (Figure 2). As with any ex-
panding program, unique challenges may
arise with future geographic expansion,
Figure 3. Conceptual Framework guiding the program development and operations of the Cervical Cancer Prevention Program in
Zambia.
doi:10.1371/journal.pmed.1001032.g003
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during our initial years as well as the
improved awareness that the program has
engendered, will likely generate unique
solutions.
Conclusion
For cancer prevention initiatives to
succeed in the developing world, programs
must avoid placing additional burdens on
health systems already stretched thin due
to competing priorities. We have demon-
strated a strategy for using the availability,
momentum, and capacity-building efforts
of vertical HIV/AIDS care and treatment
programs to implement other disease-
specific initiatives such as cervical cancer
prevention [19]. By integrating a setting-
appropriate protocol for cervical cancer
prevention into public health infrastruc-
tures, and promoting shared leadership
with government ownership, our program
has not just saved lives [11], but has also
established a new solution for routine
prevention intervention in resource-con-
strained environments.
Author Contributions
Conceived and designed the experiments:
MHM VVS SK KSP CC GM VM MLH
SHV JSS GPP. Wrote the first draft: VVS
MHM GPP. Wrote the manuscript: MHM
VVS SK KSP CC GM VM MLH SHV JSS
GPP. ICMJE criteria for authorship read and
met: MHM VVS SK KSP CC GM VM MLH
SHV JSS GPP. Agree with the manuscript’s
results and conclusions: MHM VVS SK KSP
CC GM VM MLH SHV JSS GPP.
References
1. Ferlay J, Shin HR, Bray F, Forman D, Mathers C,
et al. (2010) Estimates of worldwide burden of
cancer in 2008: GLOBOCAN 2008. Int J Cancer
127: 2893–2917.
2. Sankaranarayanan R, Esmy PO, Rajkumar R,
Muwonge R, Swaminathan R, et al. (2007) Effect
of visual screening on cervical cancer incidence
and mortality in Tamil Nadu, India: a cluster-
randomised trial. Lancet 370: 398–406.
3. Blumenthal PD, Gaffikin L, Deganus S, Lewis R,
Emerson M, et al. (2007) Cervical cancer
prevention: safety, acceptability, and feasibility
of a single-visit approach in Accra, Ghana.
Am J Obstet Gynecol 196: 407. e401–408;
discussion 407 e408–409.
4. Gaffikin L, Blumenthal PD, Emerson M,
Limpaphayom K (2003) Safety, acceptability,
and feasibility of a single-visit approach to
cervical-cancer prevention in rural Thailand: a
demonstration project. Lancet 361: 814–820.
5. Sankaranarayanan R, Boffetta P (2010) Research
on cancer prevention, detection and management
in low- and medium-income countries. Ann
Oncol 21: 1935–1943.
6. Gakidou E, Nordhagen S, Obermeyer Z (2008)
Coverage of cervical cancer screening in 57
countries: low average levels and large inequali-
ties. PLoS Med 5: e132. doi:10.1371/journal.
pmed.0050132.
7. Mwanahamuntu MH, Sahasrabuddhe VV,
Pfaendler KS, Mudenda V, Hicks ML, et al.
(2009) Implementation of ‘see-and-treat’ cervical
cancer prevention services linked to HIV care in
Zambia. AIDS 23: N1–N5.
8. Parham GP, Mwanahamuntu MH, Pfaendler KS,
Sahasrabuddhe VV, Myung D, et al. (2010) eC3–
a modern telecommunications matrix for cervical
cancer prevention in Zambia. J Low Genit Tract
Dis 14: 167–173.
9. Parham GP, Sahasrabuddhe VV, Mwana-
hamuntu MH, Shepherd BE, Hicks ML, et al.
(2006) Prevalence and predictors of squamous
intraepithelial lesions of the cervix in HIV-
infected women in Lusaka, Zambia. Gynecol
Oncol 103: 1017–1022.
10. Sahasrabuddhe VV, Mwanahamuntu MH,
Vermund SH, Huh WK, Lyon MD, et al.
(2007) Prevalence and distribution of HPV
genotypes among HIV-infected women in Zam-
bia. Br J Cancer 96: 1480–1483.
11. Parham GP, Mwanahamuntu MH, Sahasra-
buddhe VV, Westfall AO, King KE, et al.
(2010) Implementation of cervical cancer preven-
tion services for HIV-infected women in Zambia:
measuring program effectiveness. HIV Therapy
4: 713–722.
12. Pfaendler KS, Mwanahamuntu MH, Sahasra-
buddhe VV, Mudenda V, Stringer JS, et al.
(2008) Management of cryotherapy-ineligible
women in a ‘‘screen-and-treat’’ cervical cancer
prevention program targeting HIV-infected wom-
en in Zambia: lessons from the field. Gynecol
Oncol 110: 402–407.
13. Chirwa S, Mwanahamuntu M, Kapambwe S,
Mkumba G, Stringer J, et al. (2010) Myths and
misconceptions about cervical cancer among
Zambian women: rapid assessment by peer
educators. Glob Health Promot 17: 47–50.
14. Farmer P, Frenk J, Knaul FM, Shulman LN,
Alleyne G, et al. (2010) Expansion of cancer care
and control in countries of low and middle
income: a call to action. Lancet 376: 1186–1193.
1 5 .S t r i n g e rJ S ,Z u l uI ,L e v yJ ,S t r i n g e rE M ,
Mwango A, et al. (2006) Rapid scale-up of
antiretroviral therapy at primary care sites in
Zambia: feasibility and early outcomes. JAMA
296: 782–793.
16. Sankaranarayanan R, Nene BM, Shastri SS,
Jayant K, Muwonge R, et al. (2009) HPV
screening for cervical cancer in rural India.
N Engl J Med 360: 1385–1394.
17. Denny L, Kuhn L, Hu CC, Tsai WY,
Wright TC, Jr. (2010) Human papillomavirus-
based cervical cancer prevention: long-term
results of a randomized screening trial. J Natl
Cancer Inst 102: 1557–1567.
18. Trope LA, Chumworathayi B, Blumenthal PD
(2009) Preventing cervical cancer: stakeholder
a t t i t u d e st o w a r dC a r e H P V - f o c u s e ds c r e e n i n g
programs in Roi-et Province, Thailand. Int J
Gynecol Cancer 19: 1432–1438.
19. Denny CC, Emanuel EJ (2008) US health aid
beyond PEPFAR: the Mother & Child Cam-
paign. JAMA 300: 2048–2051.
20. Qiao YL, Sellors JW, Eder PS, Bao YP, Lim JM,
et al. (2008) A new HPV-DNA test for cervical-
cancer screening in developing regions: a cross-
sectional study of clinical accuracy in rural China.
Lancet Oncol 9: 929–936.
PLoS Medicine | www.plosmedicine.org 5 May 2011 | Volume 8 | Issue 5 | e1001032